ArticleCancer immunology, immunotherapy : CII2007

Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion.

Flavia Brunstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.